SAN-61

N/A

Report date: 2022/01/24 17:16:41

NME

Base Information

Drug NameSAN-61

Drug Alias NameSAN-61SAN-161

ClassificationSmall moleculesNatural product/Extract

Mechanisms of ActionMicrotubule-associated protein tau inhibitorsBeta amyloid A4 protein inhibitors

TargetsMicrotubule-associated protein tauBeta amyloid A4 protein

Therapy Area/IndicationsAlzheimer Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesDiamedica

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesDiamedica

Active IndicationsN/A

Inactive IndicationsAlzheimer Disease

ATC CodeN/A